BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 21873881)

  • 1. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database).
    Baldasseroni S; Urso R; Orso F; Bianchini BP; Carbonieri E; Cirò A; Gonzini L; Leonardi G; Marchionni N; Maggioni AP;
    J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):723-31. PubMed ID: 21873881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry.
    Baldasseroni S; Orso F; Fabbri G; De Bernardi A; Cirrincione V; Gonzini L; Fumagalli S; Marchionni N; Midi P; Maggioni AP;
    Cardiology; 2010; 116(2):79-88. PubMed ID: 20516683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients.
    DeWolfe A; Lopez B; Arcement LM; Hebert K
    Clin Cardiol; 2010 Dec; 33(12):E13-7. PubMed ID: 21184540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.
    Gheorghiade M; Abraham WT; Albert NM; Gattis Stough W; Greenberg BH; O'Connor CM; She L; Yancy CW; Young J; Fonarow GC;
    Eur Heart J; 2007 Apr; 28(8):980-8. PubMed ID: 17309900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia.
    Madan VD; Novak E; Rich MW
    Circ Heart Fail; 2011 Sep; 4(5):637-43. PubMed ID: 21673193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.
    Mohammed AA; van Kimmenade RR; Richards M; Bayes-Genis A; Pinto Y; Moore SA; Januzzi JL
    Circ Heart Fail; 2010 May; 3(3):354-61. PubMed ID: 20332419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of sodium abnormalities in patients hospitalized for heart failure.
    Shorr AF; Tabak YP; Johannes RS; Gupta V; Saltzberg MT; Costanzo MR
    Congest Heart Fail; 2011; 17(1):1-7. PubMed ID: 21272220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
    Balling L; Kistorp C; Schou M; Egstrup M; Gustafsson I; Goetze JP; Hildebrandt P; Gustafsson F
    J Card Fail; 2012 May; 18(5):351-8. PubMed ID: 22555263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatremia as predictor of worse outcome in real world patients admitted with acute heart failure.
    Arévalo Lorido JC; Carretero Gómez J; Formiga F; Montero Pérez-Barquero M; Trullás Vila JC; Aramburu Bodas O; Ceresuela LM;
    Cardiol J; 2013; 20(5):506-12. PubMed ID: 24469874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
    Gheorghiade M; Rossi JS; Cotts W; Shin DD; Hellkamp AS; Piña IL; Fonarow GC; DeMarco T; Pauly DF; Rogers J; DiSalvo TG; Butler J; Hare JM; Francis GS; Stough WG; O'Connor CM
    Arch Intern Med; 2007 Oct; 167(18):1998-2005. PubMed ID: 17923601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure.
    Balling L; Schou M; Videbæk L; Hildebrandt P; Wiggers H; Gustafsson F;
    Eur J Heart Fail; 2011 Sep; 13(9):968-73. PubMed ID: 21743065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
    Klein L; O'Connor CM; Leimberger JD; Gattis-Stough W; Piña IL; Felker GM; Adams KF; Califf RM; Gheorghiade M;
    Circulation; 2005 May; 111(19):2454-60. PubMed ID: 15867182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of the influence of the guideline on the treatment of chronic congestive heart failure in the elderly].
    Liu J; Ma JP; Huang JH; Wang L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Oct; 22(10):606-9. PubMed ID: 20977844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of beta-blockers in chronic congestive heart failure.
    Mahanonda N; Samranthin M; Panyarachun S
    J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure.
    Packer M; Lee WH; Kessler PD; Gottlieb SS; Bernstein JL; Kukin ML
    Circulation; 1987 May; 75(5 Pt 2):IV80-92. PubMed ID: 2882867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
    Rossi J; Bayram M; Udelson JE; Lloyd-Jones D; Adams KF; Oconnor CM; Stough WG; Ouyang J; Shin DD; Orlandi C; Gheorghiade M
    Acute Card Care; 2007; 9(2):82-6. PubMed ID: 17573581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.